American Healthcare REIT, Inc. (AHR)

CTI BioPharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 1, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	6,281	4,350	-	-	-	-
Enterprise Value	8,027	6,427	-	-	-	-
Last Close Price	38.89	27.99	-	-	-	-
Price/FFO Ratio	22.92	22.22	-	-	-	-
Price/AFFO Ratio	-	22.25	-	-	-	-
PS Ratio	2.66	2.11	-	-	-	-
PB Ratio	2.73	1.89	-	-	-	-
P/OCF Ratio	25.88	24.70	-	-	-	-
EV/Sales Ratio	3.81	3.11	-	-	-	-
EV/EBITDA Ratio	22.77	18.71	-	-	-	-
EV/EBIT Ratio	57.19	50.09	-	-	-	-
Debt / Equity Ratio	0.80	0.81	1.92	1.72	1.37	1.75
Debt / EBITDA Ratio	4.72	4.91	8.29	9.55	13.67	9.50
Asset Turnover	0.46	0.46	0.40	0.35	0.32	0.37
Inventory Turnover	86.64	87.74	79.78	69.48	49.63	42.28
Quick Ratio	1.09	1.04	0.50	0.45	0.22	1.42
Current Ratio	1.39	1.34	0.68	0.61	0.30	1.83
Return on Equity (ROE)	-1.77%	-1.89%	-4.95%	-4.22%	-3.67%	0.81%
Return on Assets (ROA)	1.91%	1.77%	0.82%	0.84%	0.09%	0.64%
Return on Capital (ROIC)	2.06%	1.90%	0.88%	0.89%	0.10%	0.69%
Earnings Yield	-0.65%	-0.87%	-	-	-	-
Dividend Yield	2.59%	3.57%	-	-	-	-
Payout Ratio	-	-	-	-	-	1248.13%
Buyback Yield / Dilution	-90.17%	-97.79%	-0.36%	-31.40%	-11.34%	1.11%
Total Shareholder Return	-87.58%	-94.22%	-0.36%	-31.40%	-11.34%	1.11%

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Real Estate template. Financial Sources.

SEC Filings: 10-K · 10-Q